{"filing":{"accession_number":"0001493152-26-033565","cik":"0001859007","ticker":"ZVSA","company_name":"ZyVersa Therapeutics, Inc.","form":"8-K","filing_date":"2026-07-16","report_date":null,"primary_document":"form8-k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1859007/000149315226033565/form8-k.htm"},"events":[{"id":18485,"run_id":16616,"accession_number":"0001493152-26-033565","anchor_item_number":null,"event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.95,"summary":"ZyVersa Therapeutics ceased trading on the OTCQB Venture Market and moved to the OTC Pink Limited Market effective July 16, 2026. This represents a downgrade in listing status and is a material transfer of listing that signals potential delisting risk or failure to maintain continued listing standards. The move from OTCQB to OTC Pink is a significant negative development for investor visibility and liquidity.","company_name":"ZyVersa Therapeutics, Inc.","ticker":"ZVSA","filing_date":"2026-07-16","form":"8-K","submitted_at":null,"items":null}],"classifications":[{"id":17311,"accession_number":"0001493152-26-033565","item_number":null,"item_title":null,"event_type":"delisting_risk","event_domain":"terminal","is_material":true,"confidence":0.95,"reasoning":"ZyVersa Therapeutics ceased trading on the OTCQB Venture Market and moved to the OTC Pink Limited Market effective July 16, 2026. This represents a downgrade in listing status and is a material transfer of listing that signals potential delisting risk or failure to maintain continued listing standards. The move from OTCQB to OTC Pink is a significant negative development for investor visibility and liquidity.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-07-16T21:01:53.230969+00:00","company_name":"ZyVersa Therapeutics, Inc.","ticker":"ZVSA","filing_date":"2026-07-16"}]}